coenzyme-q10 has been researched along with Cachexia* in 5 studies
1 review(s) available for coenzyme-q10 and Cachexia
Article | Year |
---|---|
Interventional nutrition for cardiac disease.
Animals with cardiac disease can have a variety of nutritional alterations for which interventional nutrition can be beneficial. Deviation from optimal body weight, both obesity and cachexia, is a common problem in cardiac patients and adversely affects the animal. Methods for maintaining optimal weight are important for good quality of life in dogs and cats with cardiac disease. Providing proper diets to prevent excess intake of sodium and chloride also is important, but severe salt restriction may not be necessary until later stages of disease. Certain nutrient deficiencies may play a role in the pathogenesis or complications of cardiac disease, but nutrients also may have effects on cardiac disease which are above and beyond their nutritional effects (nutritional pharmacology). Supplementation of nutrients such as taurine, carnitine, coenzyme Q10, and omega-3 polyunsaturated fatty acids may have benefits in dogs or cats with cardiac disease through a number of different mechanisms. By addressing each of these areas maintaining optimal weight, avoiding nutritional deficiencies and excesses, and providing the benefits of nutritional pharmacology, optimal patient management can be achieved. Topics: Animals; Antioxidants; Cachexia; Cat Diseases; Cats; Coenzymes; Dietary Supplements; Dog Diseases; Dogs; Fatty Acids, Omega-3; Heart Diseases; Magnesium Deficiency; Potassium Deficiency; Taurine; Ubiquinone; Vitamins | 1998 |
4 other study(ies) available for coenzyme-q10 and Cachexia
Article | Year |
---|---|
Effects of Combined Treatment with Branched-Chain Amino Acids, Citric Acid, L-Carnitine, Coenzyme Q10, Zinc, and Various Vitamins in Tumor-Bearing Mice.
A functional dietary supplement (FDS) containing Coenzyme Q10, branched-chain amino acids and L-carnitine was administered to tumor-bearing mice, investigating its effects on tumor and muscle tissues. Experiment (A): B16 melanoma cells were implanted subcutaneously into the right side of the abdomen of 8- to 9-week-old C57BL/6J mice. The mice were divided into two groups: a FDS group that received oral administration of FDS (n=10), and a control group that received oral administration of glucose (n=10). The moribund condition was used as the endpoint, and median survival time was determined. Experiment (B): On day 21 after tumor implantation, tumors, soleus muscle, gastrocnemius muscle, and suprahyoid muscles were collected. Tumor and muscle weight and other aspects were evaluated in each group: FDS group (n=15) and control group (n=15). The median survival time was comparable (21 d in the FDS group vs. 18 d in the control group, p=0.30). However, cumulative food intake was significantly higher in the FDS group than the control group (p=0.011). Metastasis of melanoma to the lung was observed in the control group but not in the FDS group (p=0.043). The weight of the suprahyoid muscles was significantly higher in the FDS group than in the control group (p=0.0045). The weight of the tumor was significantly lower in the FDS group than in the control group (p=0.013). The results possibly suggest oral administration of FDS in tumor-bearing mice enhances the maintenance of suprahyoid muscles, resulting in an extended feeding period and suppression of tumor growth and metastasis. Topics: Amino Acids, Branched-Chain; Animals; Cachexia; Carnitine; Citric Acid; Dietary Supplements; Eating; Male; Melanoma, Experimental; Mice, Inbred C57BL; Micronutrients; Muscle, Skeletal; Ubiquinone; Vitamins; Zinc | 2017 |
Statins, coenzyme Q10, and cachexia: what's the link?
Topics: Cachexia; Coenzymes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Ubiquinone | 2007 |
Energy-modulating vitamins--a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma.
Mitochondria are the major intracellular organelles producing ATP molecules via the electron transport chain. Cancer cells have a deviant energy metabolism, and a high rate of glycolysis is related to a high degree of dedifferentiation and proliferation. The overall net ATP production is diminished with cancer, which ultimately leads to cancer cachexia. The present study was designed to investigate the altered energy metabolism in cancer cells and to enhance ATP production in the normal host cell metabolism by enhancing the activities of mitochondrial enzymes, using energy-modulating vitamins, and thus prevent cancer cachexia. Female Sprague-Dawley rats were selected for the experimental study. Mammary carcinoma was induced by the oral administration of 7,12-dimethylbenz[a]anthracene (25 mg/kg body weight), and treatment was started by the oral administration of the energy-modulating vitamins riboflavin (45 mg/kg body weight per d), niacin (100 mg/kg body weight per d) and coenzyme Q10 (40 mg/kg body weight per d) for 28 d. Mitochondria were isolated from the mammary gland and liver of all four groups, and the Krebs cycle and oxidative phosphorylation enzymes were assayed. In mammary carcinoma-bearing animals, the activities of the Krebs cycle and oxidative phosphorylation enzymes were significantly decreased. These activities were restored to a greater extent in animals treated with energy-modulating vitamins. From these experimental results, one may hypothesize that the combination therapy of energy-modulating vitamins could be of major therapeutic value in breast cancer. Topics: Adenosine Triphosphate; Administration, Oral; Animals; Antioxidants; Cachexia; Citric Acid Cycle; Coenzymes; Drug Therapy, Combination; Energy Metabolism; Female; Liver; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mitochondria; Niacin; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Riboflavin; Ubiquinone; Vitamin B Complex | 2005 |
Coenzymes Q9 and Q10 in skeletal and cardiac muscle in tumour-bearing exercising rats.
Physical exercise increases metabolic rate, and induces both adaptational biogenesis of mitochondria in skeletal muscle and an increase in antioxidant capacity. The onset of experimental anorexia and cachexia can be delayed by voluntary exercise. As skeletal muscle is the main target for cancer cachexia, we determined the levels of coenzymes Q9 and Q10 in skeletal muscle from tumour-bearing exercising rats, and compared them to those of sedentary tumour-bearers and controls. Both tumour-bearing groups had increased levels of coenzymes Q9 and Q10 in the anterior tibial muscle (P < 0.05 for exercised animals). In the soleus muscle, only the tumour-bearing exercising animals demonstrated an increase in the levels of both coenzymes (P < 0.05). In cardiac muscle, the presence of tumour and exercise reduced the levels of coenzymes below that of sedentary controls. Exercise counteracted the anaemia in the tumour-bearing host (P < 0.05). In conclusion, the increase in antioxidant capacity in skeletal muscle indicates a defence mechanism in the tumour-bearing hosts which is augmented by physical exercise. Topics: Animals; Cachexia; Coenzymes; Energy Metabolism; Female; Muscle, Skeletal; Myocardium; Neoplasms, Experimental; Physical Conditioning, Animal; Rats; Rats, Inbred WF; Ubiquinone | 1995 |